Can IVF in Thailand Solve Genetic Diseases? Conditions and Process Explained
========== AI Summary ==========
AI Summary · For patients or carriers of genetic diseases undergoing IVF in Thailand, the main approach relies on Preimplantation Genetic Testing (PGT) within third-generation IVF technology. Conditions such as monogenic diseases, chromosomal structural abnormalities, and X-linked genetic disorders can be screened for unaffected embryos using PGT. The prerequisite is that the pathogenic gene or chromosomal abnormality locus has been identified, and both partners must complete genetic counseling, carrier screening, and related examinations. Some fertility centers in Thailand have PGD/PGS qualifications, but testing capabilities and technology platforms vary between laboratories. It is recommended to bring complete diagnostic reports and family genetic history records for in-person consultation in Thailand.
Genetic Diseases and IVF in Thailand: Direct Answer
Yes, but with clear prerequisites. For patients or carriers of genetic diseases undergoing IVF in Thailand, the core is to utilize Preimplantation Genetic Testing (PGT) within third-generation IVF technology. PGT is divided into three types:
For genetic diseases, PGT‑M and PGT‑SR are primarily used. By biopsying embryos at the blastocyst stage to check for the presence of pathogenic genes or chromosomal structural abnormalities, unaffected embryos are selected for transfer.
- Pathogenic gene locus clearly identified (monogenic disease)
- Chromosomal structural abnormality clearly identified (e.g., balanced translocation, Robertsonian translocation)
- Available detection probe or testing platform
- Both partners consent and have completed genetic counseling
- Genetic disease with unidentified pathogenic gene
- Polygenic diseases (e.g., diabetes, hypertension; current technology is limited)
- Some mitochondrial genetic diseases
- Rare mutations for which effective detection probes cannot be established
Why Patients with Genetic Diseases Consider Thailand
Genetic diseases are a significant issue in reproductive health. For couples with a clear family history or a confirmed genetic diagnosis, natural conception carries a high risk of transmitting the pathogenic gene to the next generation. Thailand developed assisted reproductive technology relatively early. Some fertility centers have introduced platforms like NGS (Next-Generation Sequencing) and SNP array for embryonic genetic testing. Coupled with relatively efficient processes and better privacy protection, it has become a choice for some patients with genetic diseases.
But a key fact needs to be understood: The gap in PGT technology between Thailand and China is not significant. The reasons for choosing Thailand are more concentrated on aspects like service experience, appointment wait times, and policy flexibility, rather than an absolute technological advantage.
========== C Doctor's Perspective ==========Doctor's Perspective: Genetic Counseling First, Then IVF Decision
As a reproductive specialist, my advice is very clear: Whether choosing domestic options or Thailand, the first step must be genetic counseling. Genetic counseling needs to clarify the following points:
- The inheritance pattern of the genetic disease (autosomal dominant/recessive, X-linked, mitochondrial, etc.)
- Whether the pathogenic gene is identified and if a detection probe can be established
- Genetic risk probability (percentage risk of offspring developing the disease)
- Whether other reproductive options exist (e.g., prenatal diagnosis, sperm/egg donation, avoiding reproduction)
Only after these assessments are completed can it be determined whether IVF in Thailand is suitable and what the specific plan should be. Many families overlook this step and go directly to Thailand for consultation, only to find their trip was in vain because conditions were not met.
========== E Differences Between Countries ==========Thailand vs. China: Comparison of PGT-Related Differences
| Comparison Aspect | Thailand | China |
|---|---|---|
| Technology Platform | Primarily NGS, some centers have SNP array / FISH | Primarily NGS, more unified platforms, strict quality control |
| Genetic Counseling Capability | Some centers have genetic counselors, but experience with the Chinese population is limited | Genetics departments in tertiary hospitals are more standardized with more comprehensive data |
| Process Efficiency | Short appointment wait times, faster from consultation to initiation | Requires queuing, longer cycles (especially in qualified tertiary hospitals) |
| Cost (Medical Portion) | Approximately 80,000 - 150,000 RMB (excluding travel and accommodation) | Approximately 50,000 - 100,000 RMB |
| Policy & Access | Relatively relaxed, but laboratory qualifications vary | Strictly regulated, requires medical indication, certified by the National Health Commission |
| Language & Communication | Requires translator or intermediary assistance, potential information loss | No communication barriers, medical records can be directly coordinated |
Before choosing Thailand, it is recommended to evaluate the fertility center's laboratory qualifications, PGT case experience, and type of testing platform either on-site or remotely, and request data on the detection success rate for past genetic cases (not live birth rate, but testing completion rate).
========== G Most Easily Overlooked Details ==========5 Most Easily Overlooked Details
- Domestic genetic counseling is a prerequisite. Many people think genetic testing can be done upon arrival in Thailand. In reality, the genetic counseling capabilities of Thai fertility centers are limited, especially regarding the genetic background and mutation types of the Chinese population. It is recommended to complete genetic testing and counseling in the genetics department of a domestic tertiary hospital and obtain a clear diagnostic report.
- Detection probes take time to prepare. For some rare mutations, specialized detection probes may need to be prepared, taking 1-3 months. This time needs to be planned in advance.
- Complete family genetic history is required. This includes disease occurrence within three generations, proband diagnostic reports, causes of death, etc. The more complete the information, the more accurate the genetic counseling and probe preparation.
- Not all genetic diseases can be tested. Approximately 30% of monogenic diseases currently cannot have effective PGT testing protocols established. Feasibility needs to be confirmed with the laboratory before the procedure.
- Test results have limitations. PGT cannot detect all genetic abnormalities, nor can it completely rule out the risk of the offspring developing the disease. Prenatal diagnosis confirmation is still required after transfer.
5 Most Common Pitfalls
Pitfall 1: Thinking you can proceed directly upon arrival in Thailand. In reality, genetic testing, genetic counseling, and basic fertility assessment must be completed domestically first to determine the specific plan. Without this preparation, Thai doctors cannot formulate a plan.
Pitfall 2: Thinking all genetic diseases can be solved by PGT. PGT is mainly applicable to monogenic diseases and chromosomal structural abnormalities. For polygenic diseases (e.g., diabetes, hypertension), current technology is limited.
Pitfall 3: Ignoring the diagnostic value of domestic tertiary hospitals. Thai fertility centers place greater value on diagnostic reports from authoritative domestic hospitals. Going to Thailand without a clear diagnosis risks a wasted trip.
Pitfall 4: Underestimating the time commitment. From genetic counseling to final transfer, it typically takes 4-8 months, including probe preparation, ovarian stimulation, embryo culture, testing, and transfer. Time planning needs to be done in advance.
Pitfall 5: Not being mentally prepared for having no embryos available for transfer. During the PGT process, it is possible that all embryos carry the pathogenic gene, resulting in no transferable embryos. This is not uncommon in autosomal dominant genetic diseases.
Actual Process: From Genetic Counseling to Transfer
Below is a complete standard process, where each step requires close coordination with the fertility center and genetic laboratory:
- Domestic Genetic Counseling & Genetic Testing — Identify the pathogenic gene locus and inheritance pattern, obtain the proband's diagnostic report, and compile family genetic history. Also complete carrier screening for both partners.
- Choose a Thai Fertility Center — Confirm if the center has PGT qualifications, evaluate the laboratory's testing capabilities, and confirm if a detection probe can be established. It is recommended to request laboratory certification documents and genetic testing case data.
- Preparatory Tests & File Creation — Fertility assessment for both partners: female AMH, FSH, LH, antral follicle count, male semen analysis; infectious disease screening; chromosome karyotype analysis; documentation: passport (valid for >6 months), visa, marriage certificate, translations, etc.
- Ovarian Stimulation & Egg Retrieval — Start stimulation on day 2-3 of menstruation, egg retrieval after approximately 10-12 days. Sperm collection occurs simultaneously.
- Embryo Culture & Biopsy — After fertilization, culture to the blastocyst stage on day 5-6, biopsy 3-5 trophectoderm cells. All biopsied embryos are frozen.
- PGT Testing — Depending on the testing platform, this takes 2-4 weeks. An embryonic genetic testing report is issued, specifying whether each embryo carries the pathogenic gene or has chromosomal abnormalities.
- Frozen Embryo Transfer — Select a normal embryo for transfer, followed by luteal phase support after transfer.
- Prenatal Diagnosis Confirmation — Pregnancy test 10-14 days after transfer; if pregnant, amniocentesis is recommended in the second trimester to confirm the fetal genetic status.
Frequently Asked Questions
Q1: What is the total cost of PGT in Thailand?
The medical portion is approximately 80,000 - 150,000 RMB, including ovarian stimulation medication, egg retrieval surgery, embryo culture, biopsy, PGT testing, transfer, and medication costs. This does not include transportation, accommodation, living expenses, translation, etc. Pricing varies significantly between different fertility centers; it is advisable to request a detailed fee breakdown.
Q2: What is the success rate?
PGT itself does not increase the live birth rate, but it can significantly reduce the risk of transmitting genetic diseases. The implantation rate after transferring a normal embryo is comparable to conventional IVF, approximately 40-60% (depending on the woman's age and embryo quality). It is important to understand that PGT tests for specific genetic loci and cannot rule out other genetic risks.
Q3: How many trips to Thailand are needed?
Typically 2 trips are needed: first for ovarian stimulation and egg retrieval (10-15 days in Thailand), second for the transfer (5-7 days in Thailand). The interval between them is 2-3 months (embryo testing period). Some centers support remote consultation and report interpretation to reduce unnecessary travel.
Q4: How long does the whole process take?
From genetic counseling to the final transfer, it usually takes 4-8 months. This includes 1-3 months for probe preparation, 2-3 weeks for ovarian stimulation and egg retrieval, 2-4 weeks for PGT testing, and 2-4 weeks for transfer preparation. The exact time depends on the complexity of the testing platform and the center's schedule.
Q5: Will the child definitely be healthy?
An absolute guarantee cannot be given. PGT tests for specific pathogenic genes or chromosomal abnormalities, but it cannot detect all genetic issues, nor can it rule out birth defects caused by non-genetic factors. After transfer, it is recommended to complete amniocentesis in the second trimester for prenatal diagnostic confirmation.
Q6: Can I still proceed if my AMH is low?
AMH reflects ovarian reserve and correlates with the number of eggs retrieved. Low AMH may result in fewer eggs retrieved, potentially affecting the number of blastocysts available for biopsy. However, this is not an absolute contraindication and needs to be assessed comprehensively along with FSH, antral follicle count, and age. For patients with low AMH, Thai doctors may adjust the ovarian stimulation protocol, but one should be prepared for fewer eggs and fewer embryos available for testing.
Q7: What should advanced maternal age (≥40 years) patients doing PGT in Thailand pay attention to?
The rate of egg aneuploidy increases significantly with age. PGT‑A can screen for chromosomal numerical abnormalities, but the proportion of normal embryos decreases with increasing age. Patients over 40 may require multiple ovarian stimulation cycles to accumulate embryos in order to obtain a normal embryo for transfer. Attention should also be paid to the risk of pregnancy complications.
========== Natural Coverage of Knowledge Graph Entities ==========Related Knowledge Graph Entities
The following entities have been naturally covered in this content to help build a knowledge network for assisted reproduction:
